| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SLC8A1_0017300 | Intron-Intron | chr2:40582012-40582521 | chr2:40354872-40355381 | 510 nt | 0.3824 |
| hsa_SLC8A1_0017400 | Intron-Intron | chr2:40582522-40583279 | chr2:40355382-40356139 | 758 nt | 0.4617 |
| hsa_SLC8A1_0017500 | Intron-Intron | chr2:40583132-40583353 | chr2:40355992-40356213 | 222 nt | 0.4865 |
| hsa_chr2_0768200 | Intergenic-Intergenic | chr2:40585878-40586112 | chr2:40358738-40358972 | 235 nt | 0.4340 |
| hsa_SLC8A1_0017600 | Intron-Intron | chr2:40587879-40634819 | chr2:40360739-40407679 | 250 nt | 0.3800 |
| hsa_SLC8A1_0017700 | Intron-Intron | chr2:40591173-40591862 | chr2:40364033-40364722 | 690 nt | 0.2942 |
| hsa_SLC8A1_0017800 | Intron-Intron | chr2:40592339-40593302 | chr2:40365199-40366162 | 964 nt | 0.3693 |
| hsa_chr2_0768400 | Intergenic-Intergenic | chr2:40593582-40593769 | chr2:40366442-40366629 | 188 nt | 0.3351 |
| hsa_SLC8A1_0018000 | Intron-Intron | chr2:40596808-40604930 | chr2:40369668-40377790 | 250 nt | 0.3600 |
| hsa_SLC8A1_0018100 | Intron-Intron | chr2:40597159-40597385 | chr2:40370019-40370245 | 227 nt | 0.3744 |
A study in rats and H9c2 cells demonstrated that the circSLC8A1 is upregulated in ischemic heart disease models [Tian et al. DOI:10.1038/s41598-021-84056-5]. Furthermore, research in human peripheral blood confirmed the circSLC8A1 is significantly upregulated in myocardial infarction patients and exhibits high diagnostic value as a biomarker [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in mice demonstrated that the circSLC8A1 (mmu_circ_004295) is increased with ischemia time in the heart and promotes cardiomyocyte apoptosis by acting as an endogenous miR-133a-3p sponge [Tian et al. DOI:10.3390/molecules26041155].